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Histocompatibility Matching and Renal Graft Survival
Today it is accepted that ABO compatibility and a negative leukocyte cross-match between recipient serum and donor lymphocytes are a sine qua non of successful renal transplantation, despite the existence of occasional well-documented exceptions when ABO incompatible or crossmatch positive grafts have functioned well (Starzl et al. 1964 , Terasaki et al. 1971 . No other histocompatibility matching system has such undisputed acceptance despite the multitude of publications which have appeared on the role of HLA antigens. This paper reviews the present situation with respect to the role of HLA antigens in graft rejection in an attempt to find out why the use of HLA matching is not clinically acceptable, and considers what needs to be done to provide a more effective matching system to reduce further the incidence of graft rejection which still remains an overriding cause of graft failure.
In 1969 Singal et al. reported the first evidence demonstrating that the chromosomal region coding for the major histocompatibility system (MHS), including the genes controlling HLA antigens, was involved in initiating graft rejection. 27 2o2 21 124 yo~~~~1 7 13 6 3 41d 2 9< 2 They reported a 92% survival for matched compared with 43 % survival for mismatched siblings at four years. This finding has been universally confirmed in all series published to date. However, there are very few data published permitting an exact analysis of donor and recipient type so that a comparison can be made between MHS identical, I haplotype matched and 2 haplotype incompatible grafts as was so elegantly demonstrated in rats by Morten Simonsen (Bilds0e et al. 1970) and later confirmed in dogs and pigs by Vriesendorp et al. (1971) and Bradley et al. (1973) . In a recent analysis of 558 sibling grafts Opelz et al. (1974) were able to report on only 30 grafts which were unequivocally 2 haplotype incompatible. Their survival at one year (59%) was considerably worse than the HLA identical grafts (90%) though very little different from those who were 1 haplotype matched (67%) or those who received an unmatched cadaver graft (51 %). More than 75 % of individuals with renal failure requiring transplantation will not have an HLA identical sibling, so that to be universally acceptable HLA matching must be demonstrated to be of value in unrelated cadaver grafts.
When unrelated cadaver grafts were first studied the nature of genetic control of HLA antigens was not fully understood. Though it was apparent in some series that there might be slightly better survival of matched grafts, many incompatible grafts survived with normal function (van Rood et al. 1969 , Morris 1971 , Batchelor & Joysey 1969 ). The first analysis to take cogniscence of the two locus hypothesis was reported by Festenstein et al. (1971) in analysis of grafts exchanged through the London Transplant Group. Later in a follow up of 349 grafts Oliver et al. (1972) showed significantly better survival of grafts matched identically for three or four antigens when compared to those matched for 2, 1 or 0 antigens (Fig 1) . There is very little difference between grafts matched for only 2, 1 or 0 antigens. In these same analyses it was possible to show a predominant importance of matching for 2nd compared to. 1st locus antigens (Figs 2 and 3). Data from the France Transplant Organization (Hors et al. 1971 ) have most clearly demonstrated the same results and a joint analysis of 918 grafts was reported in 1974 (Dausset et al. 1974 (1974) . This clearly illustrates the difficulty that even large collaborative organizations have in achieving identity for HLA 1st and 2nd locus antigens. However, even when this is achieved it is clear that failure from rejection in these patients is higher than that seen in the HLA identical sibling grafts. It has been suggested that incompatibility at the 3rd HLA locus and even the MLC locus may be responsible. If this is so, it must be accepted that it will never be possible to find donor grafts matched identically for all five loci, for all recipients waiting for a transplant at this time. When regional centres, such as that in Melbourne, can report 65% functioning grafts at one year in a series of 122 grafts amongst which only six were matched for 3 or 4 HLA antigens (Mathew et al. 1974) , it is clear that any matching system which clinicians would apply as a routine rather than pay lip service to, as at present, must be considerably simpler than the current serologist's conception of the HLA supergene. Such a system (namely 4a/4b locus) already exists, though relatively little attention has been paid to it since 1969/70. This genetic system was first discovered by van Rood & van Leeuwen in 1963, but in recent years there has been intense debate as to whether it is a separate genetic system in linkage with the 2nd locus (van Surviv in monwhs Recently, evidence from anthropological studies has shown different association between 4a/4b antigens and 2nd locus antigens in different populations (Oliver & Festenstein 1975 , 1976 , so slightly tipping the balance in favour of the hypothesis of separate loci. At the time when the London Transplant Group collaboration was organizing kidney exchange, sera 4a/4b typing were not used. However, because of the known association with 2nd locus antigens it is possible within a caucasoid population to make a maximum likelihood prediction of 4a/4b phenotype. Fig 4 shows an analysis of 349 grafts from the London Transplant Group data broken down into four groups, i.e. those which were identical for both 2nd locus antigens; those who, on the basis of the inclusion phenomena of 2nd locus antigens into either 4a or 4b inclusion group, could be said to be inclusion group identical (Allen et al. 1970 , d'Amaro 1975 ; those who, because of an unknown antigen in either donor or recipient, it was only possible to consider as inclusion group compatible; and finally, those where the known 2nd locus antigen of the donor belonged to a different 4a/4b inclusion from those of the recipient. The difference in survival of inclusion group identical compared to inclusion grcoup incompatible (58% v 39% at 12 months, P<0.05) is almost as I great as that between 2 identity and 0 identity at the 2nd locus (63 % v 42% at 12 monthssee Fig 3) . Though these data are encouraging it will be necessary to have other more substantial data from groups using the latest available 4a/4b sera which, when used in the last .workshop group, gave almost as good antigen definition as was available for most 2nd locus antigens. However, from the data presented it is apparent that even 4a/4b matching will neither guarantee survival nor predict certain failure, though it may give nearly as good a prediction of graft survival as achieved by matching for the minutiae of HLA 1st and 2nd locus, with considerably less difficulty.
Other factors must be involved and recently it has become clear that there are some circumstances under which it may be possible to induce unresponsiveness to histocompatibility antigens (Opelz et al. 1973) . Females, particularly after multiple pregnancies, are relatively unresponsive to male grafts (Oliver 1974) and patients who have received multiple blood transfusions without producing antibodies have significantly better survival than patients who have not received transfusion (Opelz et al. 1973 , Oliver et al. 1973 ). However, those who respond to transfusion by producing lymphocytotoxins do significantly worse the more they are transfused (Oliver et al. 1973 systems that so-called minor histocompatibility antigens which may not materially affect organ -grafts in non-immune individuals can significantly shorten survival after hyperimmunization (Simonsen 1962). To date there has been relatively little information on the effect of hyperimmunization on graft survival in situations which are incompatible for antigen systems other than the HLA. It has been established some time now that A1-A2 and P1-*p incompatibility in immunized recipients causes accelerated skin graft rejection (Ceppellini et al. 1966 ), but to date there have been no substantial data published on the role of these antigens in immunized recipients of renal grafts. However, a preliminary analysis of the London Transplant data does suggest that there might be effects of both these antigen systems. In Table 1 there is a suggestion that Blood Group A recipients may be doing better after receiving Group 0 grafts than when those receiving Group A grafts, about 10 % of which on random chance would be incompatible A1 to A2. Table 2 shows that recipients who are positive for the antigen p do significantly worse than those who are P positive. It is likely that 80 % of these p recipients would have received a P incompatible graft and it is almost certain that they would have previously been transfused with P incompatible blood. Though one would not dream of taking action on the basis of these data, surely there ought at least to be an attempt to collect more information on this subject. The observation on skin grafts was made nearly ten years ago. To date, apart from some information from the American Transplant Registry on the blood group P system which was published by Gleeson & Murray (1967) there are no data available to confirm or repute this suggestion.
Summary
There can be no doubt from the r6sults of kidney grafts between HLA identical siblings that matching for this antigen complex is important in determining graft survival. However, more than 75% of patients with renal failure will not have a suitably matched sibling, and when considering unrelated grafts the benefit of HLA matching, though demonstrable in most series, is relatively small compared to the considerable problem there is in finding identical donor matched for 1st and 2nd locus let alone 3rd or MLC locus antigens. Data from an inclusion analysis are presented which suggest that matching for 4a and 4b antigens alone might give as impressive a result as matching for 1st and 2nd locus antigens (with considerable less difficulty) from a matched donor. The problem of matching hyperimmunized recipients is discussed and the considerable dearth of information on the effect of A1 to A2 and PI to p incompatibility in such recipients is highlighted.
